Effectiveness and safety of anti-BCMA chimeric antigen receptor T-cell treatment in relapsed/refractory multiple myeloma: a comprehensive review and meta-analysis of prospective clinical trials

Effectiveness and safety of anti-BCMA chimeric antigen receptor T-cell treatment in relapsed/refractory multiple myeloma: a comprehensive review and meta-analysis of prospective clinical trials

Background: Chimeric antigen receptor T cells treatment targeting B cell maturation antigen (BCMA) is an emerging treatment option for relapsed/refractory multiple myeloma (RRMM) and has demonstrated outstanding outcomes in clinical studies.Objective: The aim of this comprehensive review and meta-an...

Full description

Bibliographic Details
Main Authors: Dingyuan Hu, Liming Chen, Diqin Yan, Wenliang Dong, Min Chen, Suping Niu, Simin Wang, Jiaojiao Zhang, Xiaoyan Nie, Yi Fang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Pharmacology
Subjects:
chimeric antigen receptor T-cell treatment
BCMA
cancer immunotherapy
multiple myeloma
effectiveness
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1149138/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1149138/full

Similar Items